2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$35.48-$0.24 (-0.69%)
Price as of Oct 02, 2026 7:30 PM EDT- $25.3BMarket Cap
- 120.90%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$35.48-$0.24 (-0.69%)
ROIV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.72 | ||
Change | +$0.22 (+0.62%) | ||
Open | $35.61 | ||
High | $36.00 | ||
Low | $35.19 | ||
Previous Close | $35.50 | ||
Volume | 4,390,006 | ||
30-Day Average Volume | 8,582,185 | ||
1-Week Change | -0.22% | ||
1-Month Change | 4.51% | ||
1-Year Change | 120.90% | ||
3-Year Change | 239.71% | ||
5-Year Change | 282.03% | ||
Fundamentals | |||
Shares Outstanding | 713.5M | ||
Total Assets | $5.3B | ||
Market Cap | $25.3B | ||
Enterprise Value | $24.1B | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$189.8M | ||
Free Cash Flow | -$270.9M | ||
EBIT | -$193.8M | ||
EBITDA | -$193.2M | ||
Net Working Capital | $4.5B | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -125 | ||
Enterprise Value/Revenue | 16,701 | ||
P/B | 6 | ||
P/E | -137 | ||
PEG | 1 | ||
Price/Free Cash Flow | -93 | ||
Price/Operating Cash Flow | -94 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue